|
On (b)(6) 2023 (b)(6) was notified by the fda via email, that report # mw5148319 had been received through the fda's medwatch program.The report was submitted by fresenius medical care, a distributor of angelini pharma inc.Infection prevention products.The report stated that a female patient experienced swelling of the neck, and severe breathing difficulties while using exsept plus antiseptic.No additional information was provided.
|
|
The root cause cannot be identified.There is limited device specific information provided, no batch number is available, and no sample for evaluation.Without a batch reference, a manufacturing and technical evaluation cannot be completed.No product quality related trend was identified for the exsept plus product.Product labeling indicates not to use the device in case of a known or suspected hypersensitivity to sodium hypochlorite.Additionally, the label warns not to inject, ingest, or inhale the product.
|